Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 94

Results For "Vice-President"

933 News Found

Pharma 4.0: Pandemic pushed reluctant pharma companies to adopt advanced technologies
News | March 04, 2021

Pharma 4.0: Pandemic pushed reluctant pharma companies to adopt advanced technologies

Pharma industry is ready to embrace technology platforms with a keen focus on automation in manufacturing and digital health investment.

DSM secures victory in patent infringement litigation against Anhui Tiger
News | March 02, 2021

DSM secures victory in patent infringement litigation against Anhui Tiger

Tiger can no longer make an important biotin intermediate using a DSM patented process.

Thermo Fisher completes acquisition of Henogen
News | January 16, 2021

Thermo Fisher completes acquisition of Henogen

Novasep's viral vector business is an excellent strategic fit as Thermo Fisher continues to expand its capabilities for cell and gene vaccines and therapies globally," said Michel Lagarde, executive vice president, Thermo Fisher.

Latest Stories

Bayer launches biotech innovation platform in China

Pete Pharma and FABRX announce strategic partnership

GSK to invest $30 billion in R&D, manufacturing in US over next 5 years

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries

Packaging